Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-04-06
DOI
10.3389/fimmu.2017.00416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
- (2016) Qi Yang et al. ANALYTICAL CHEMISTRY
- Cancer Immunology and Immunotherapy
- (2016) AMMAR SUKARI et al. ANTICANCER RESEARCH
- Humanized Mouse Xenograft Models: Narrowing the Tumor–Microenvironment Gap
- (2016) J. Jason Morton et al. CANCER RESEARCH
- Patient-derived xenografts as tools in pharmaceutical development
- (2016) E Izumchenko et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
- (2016) Grant H. Petersen et al. JOURNAL OF CONTROLLED RELEASE
- Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer
- (2016) Hilary Shmeeda et al. JOURNAL OF DRUG TARGETING
- Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
- (2016) Carlos Pérez-Medina et al. Nature Communications
- Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes
- (2016) Yaqing Qie et al. Scientific Reports
- A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment
- (2015) Robert S. Kerbel CANCER JOURNAL
- Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models
- (2015) Ken Ito et al. CANCER SCIENCE
- Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses
- (2015) Manoj K. Sabnani et al. Nanomedicine-Nanotechnology Biology and Medicine
- M2 polarization enhances silica nanoparticle uptake by macrophages
- (2015) Jessica Hoppstädter et al. Frontiers in Pharmacology
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth
- (2014) S.M. Moghimi JOURNAL OF CONTROLLED RELEASE
- Cancer nanomedicines: closing the translational gap
- (2014) Alberto Gabizon et al. LANCET
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
- (2013) Stephen W. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Pegylated Liposomal Doxorubicin in Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials
- (2013) J.-M. Gibson et al. ONCOLOGIST
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- Vaccine delivery using nanoparticles
- (2013) Anthony E. Gregory et al. Frontiers in Cellular and Infection Microbiology
- Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
- (2013) Tom Donnem et al. Cancer Medicine
- Questioning the use of PEGylation for drug delivery
- (2013) Johan J. F. Verhoef et al. Drug Delivery and Translational Research
- Liposome imaging agents in personalized medicine
- (2012) Anncatrine L. Petersen et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
- (2012) Janice A. Nagy et al. CLINICAL & EXPERIMENTAL METASTASIS
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
- (2010) Masako Ichihara et al. Pharmaceutics
- Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial
- (2009) Maurie Markman et al. GYNECOLOGIC ONCOLOGY
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution
- (2008) Marina A. Dobrovolskaia et al. MOLECULAR PHARMACEUTICS
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started